On-Novations公司购买Inka Health公司,通过先进的AI技术加强癌症研究。 Onco-Innovations buys Inka Health to enhance cancer research through advanced AI technology.

On-Involutions公司收购了加拿大AI软件公司Inka Health公司,以加强其癌症研究和药物开发能力。 Onco-Innovations has acquired Inka Health, a Canadian AI software company, to boost its cancer research and drug development capabilities. Inka的SynoGraphTM平台将各种数据类型结合起来,以便更深入地了解疾病机制,从而有可能导致更个性化的癌症治疗。 Inka's SynoGraph™ platform combines various data types to provide deeper insights into disease mechanisms, potentially leading to more personalized cancer treatments. 这项交易于2025年1月22日完成,涉及Onco公司向Inka的前股东发行1 775 147份共同股份。 This deal, completed on January 22, 2025, involves Onco issuing 1,775,147 common shares to Inka's former shareholders. 购置的目的是简化药物发现和临床研究,减少时间和费用。 The acquisition aims to streamline drug discovery and clinical research, reducing time and costs.